NCT00638079View on ClinicalTrials.gov

Evaluating the Effect of Food on Absorption of Megace ES

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
PharmacokineticsBioavailabilityAbsorption
Interventions
DRUG

Megestrol acetate oral suspension 625 mg/5 mL

Megestrol acetate oral suspension 625 mg/5 mL. Single dose (5 mL) administered with a high fat meal

DRUG

Megestrol acetate oral suspension 625 mg/5 mL

Megestrol acetate oral suspension 625 mg/5 mL. Single dose (5 mL) administered following an overnight fast

Trial Locations (1)

H3X 2H9

SFBC Anapharm, Montreal (Quebec)

Sponsors
All Listed Sponsors
collaborator

SFBC Anapharm

INDUSTRY

lead

Endo Pharmaceuticals

INDUSTRY